Emily E Ricotta1, Amanda Palmer, Katie Wymore, Paula Clogher, Nadine Oosmanally, Trisha Robinson, Sarah Lathrop, Jillian Karr, Julie Hatch, John Dunn, Patricia Ryan, David Blythe. 1. Emily E. Ricotta, Amanda Palmer, Patricia Ryan, and David Blythe are with the Maryland Department of Health and Mental Hygiene, Baltimore. Katie Wymore is with Public Health Foundation Enterprises, Oakland, CA. Paula Clogher is with the Yale School of Public Health, New Haven, CT. Nadine Oosmanally is with the Georgia Department of Public Health, Atlanta. Trisha Robinson is with the Minnesota Department of Health, St. Paul. Sarah Lathrop is with the University of New Mexico, Alburquerque. Jillian Karr is with the New York State Department of Health, Rochester. Julie Hatch is with the Oregon Health Authority, Public Health Division, Portland. John Dunn is with the Tennessee Department of Health, Nashville.
Abstract
OBJECTIVES: The objective of this study was to determine the role international travel plays in US Campylobacter epidemiology and antimicrobial resistance. METHODS: In this study, epidemiological and antimicrobial resistance data, encompassing the years 2005 to 2011, from 10 sites participating in the Foodborne Diseases Active Surveillance Network were linked. The 10 sites are represented by 7 states that conducted surveillance on a statewide level, and 3 states which conducted county-level surveillance. Cases of Campylobacter among persons with history of international travel in the week prior to illness were compared with cases among individuals with no international travel. RESULTS: Approximately 18% of Campylobacter infections were estimated to be associated with international travel, and 60% of international travel-associated infections had a quinolone-resistant Campylobacter isolate. CONCLUSIONS: We confirm that international travel plays a significant role in campylobacteriosis diagnosed in the United States. Recognizing this is important to both medical management decisions and understanding burden and attribution estimates of US campylobacteriosis and antibiotic-resistant campylobacteriosis.
OBJECTIVES: The objective of this study was to determine the role international travel plays in US Campylobacter epidemiology and antimicrobial resistance. METHODS: In this study, epidemiological and antimicrobial resistance data, encompassing the years 2005 to 2011, from 10 sites participating in the Foodborne Diseases Active Surveillance Network were linked. The 10 sites are represented by 7 states that conducted surveillance on a statewide level, and 3 states which conducted county-level surveillance. Cases of Campylobacter among persons with history of international travel in the week prior to illness were compared with cases among individuals with no international travel. RESULTS: Approximately 18% of Campylobacter infections were estimated to be associated with international travel, and 60% of international travel-associated infections had a quinolone-resistant Campylobacter isolate. CONCLUSIONS: We confirm that international travel plays a significant role in campylobacteriosis diagnosed in the United States. Recognizing this is important to both medical management decisions and understanding burden and attribution estimates of US campylobacteriosis and antibiotic-resistant campylobacteriosis.
Authors: Heidi D Kassenborg; Kirk E Smith; Duc J Vugia; Therese Rabatsky-Ehr; Martha R Bates; Michael A Carter; Nellie B Dumas; Maureen P Cassidy; Nina Marano; Robert V Tauxe; Frederick J Angulo Journal: Clin Infect Dis Date: 2004-04-15 Impact factor: 9.079
Authors: Simon Pollett; Claudio Rocha; Rito Zerpa; Lilian Patiño; Augusto Valencia; Máximo Camiña; José Guevara; Martha Lopez; Nancy Chuquiray; Eduardo Salazar-Lindo; Carlos Calampa; Martín Casapia; Rina Meza; Maruja Bernal; Drake Tilley; Michael Gregory; Ryan Maves; Eric Hall; Franca Jones; C Sofia Arriola; Marieke Rosenbaum; Juan Perez; Matthew Kasper Journal: BMC Infect Dis Date: 2012-08-16 Impact factor: 3.090
Authors: Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin Journal: Emerg Infect Dis Date: 2011-01 Impact factor: 6.883